HOME >> MEDICINE >> NEWS
EDCTP welcomes G8 support for HIV/AIDS vaccine development

The Hague, the Netherlands On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and commitment to accelerating the research on and availability of a vaccine against HIV, one of the major impediments today to sustainable development of underprivileged countries.

The European and Developing Countries Clinical Trials Partnership (EDCTP) believes that critical impediments to development such as the ones inflicted by HIV/AIDS, must be addressed by having the Developing Countries benefit from both the tools resulting from research (based on their public health needs), and the systems which they have acquired to assess those tools independently.

The renewed emphasis about HIV expressed by the G8 Leaders is welcome, timely and only too needed. At the same time, we must not forget that the same challenges are being faced with tuberculosis and malaria, as well as other, more neglected causes of illness and poverty in the developing world. The EDCTP strongly believes that ultimately the outcome of this initiative and others will depend on the ownership and commitment to this vision by the partners, and by having the concerned countries play a central role.

Adapted interventions are essential to reduce the burden caused by these diseases. Current approaches to vaccine development suffer from common problems and shortcomings, which are shared by all of these diseases. The EDCTP believes that a common, coordinated approach will benefit and expedite developments in general (i.e. capacities and methodologies).

There are today insufficient capacities and overall capabilities to test products clinically in high-burden countries. The EDCTP upholds high scientific and ethic
'"/>

Contact: Sandor Vrij
vry@edctp.org
31-70-344-0885
Netherlands Organization for Scientific Research
11-Jun-2004


Page: 1 2

Related medicine news :

1. Media invitation first annual EDCTP Forum
2. South African MRC hosts the African branch office of EDCTP Secretariat
3. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
4. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
5. Emergency department study supports giving dehydrated children fluids by mouth
6. Early supported discharge services can reduce long term dependency for stroke patients
7. Care of rural stroke patients improves with telephone support
8. Review supports link between HRT and stroke
9. Chamomile tea: New evidence supports health benefits
10. Psychological support helps adolescents with chronic fatigue syndrome
11. Social supports lessen effects of maltreatment on children vulnerable to depression

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EDCTP welcomes support for HIV AIDS vaccine development

(Date:10/31/2014)... one out of four older Americans say that either ... unwanted medical treatment, according to the latest issue of ... Aging Report ( PP&AR ), which goes on ... when they fail to honor patients, end-of-life health care ... Illness Care: Issues and Options ," features 12 articles ...
(Date:10/31/2014)... Gold Medal Wine Club is making ... gifts for the wine novice and enthusiasts on their lists ... Special , which Early Bird shoppers receive discounts as high ... membership. , Gift Givers must place their orders before ... discounts, Gold Medal Wine Club adds more value to its ...
(Date:10/31/2014)... York (PRWEB) October 31, 2014 North ... Eye in Garden City, Long Island and the addition ... their medical staff, according to North Shore Eye Care ... the Emeritus Acting Chairman of the Department of Ophthalmology ... successful practice in Garden City for more than 30 ...
(Date:10/31/2014)... combination that can trigger the self-destruct process in lung ... according to research that will be presented at the ... next week*. , When healthy cells are no longer ... self destruction. But cancer cells swerve away from this ... grow out of control – causing tumours to form. ...
(Date:10/31/2014)... 31, 2014 FindSurrogateMother.com conveys ... gifts of life — building a family through surrogacy. ... mothers and donors with hopeful intended parents in turn ... , It’s a collective aptitude of surrogate mothers, intended ... and fertility clinics that help provide these connections — ...
Breaking Medicine News(10 mins):Health News:Advance directives can benefit patients, families, and health care system 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Scientists trigger self-destruct switch in lung cancer cells 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... Oct. 31, 2014  Australian biopharmaceutical company Specialised Therapeutics ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will be ... with metastatic pancreatic cancer from 1 November. ... is the 5 th most common cause of ... cancer deaths, with the lowest 5-year survival of all ...
(Date:10/31/2014)... , October 31, 2014 ... a clinical-stage pharmaceutical company focused on the development ... company will host a conference call to discuss ... trial of ORMD-0801, the company,s proprietary oral insulin ... November 3, 2014 at 10:00 a.m. Eastern time. ...
Breaking Medicine Technology:Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3
Cached News: